Literature DB >> 22523197

Can intensive longitudinal monitoring of individuals advance cancer research?

C Anthony Blau1.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22523197      PMCID: PMC3360897          DOI: 10.1634/theoncologist.2012-0122

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


× No keyword cloud information.
  15 in total

1.  Clonal architecture of secondary acute myeloid leukemia.

Authors:  Matthew J Walter; Dong Shen; Li Ding; Jin Shao; Daniel C Koboldt; Ken Chen; David E Larson; Michael D McLellan; David Dooling; Rachel Abbott; Robert Fulton; Vincent Magrini; Heather Schmidt; Joelle Kalicki-Veizer; Michelle O'Laughlin; Xian Fan; Marcus Grillot; Sarah Witowski; Sharon Heath; John L Frater; William Eades; Michael Tomasson; Peter Westervelt; John F DiPersio; Daniel C Link; Elaine R Mardis; Timothy J Ley; Richard K Wilson; Timothy A Graubert
Journal:  N Engl J Med       Date:  2012-03-14       Impact factor: 91.245

2.  Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers.

Authors:  Ryohei Katayama; Alice T Shaw; Tahsin M Khan; Mari Mino-Kenudson; Benjamin J Solomon; Balazs Halmos; Nicholas A Jessop; John C Wain; Alan Tien Yeo; Cyril Benes; Lisa Drew; Jamal Carlos Saeh; Katherine Crosby; Lecia V Sequist; A John Iafrate; Jeffrey A Engelman
Journal:  Sci Transl Med       Date:  2012-01-25       Impact factor: 17.956

3.  Targeting tyrosine kinases in cancer: the second wave.

Authors:  Jose Baselga
Journal:  Science       Date:  2006-05-26       Impact factor: 47.728

4.  Duke scandal highlights need for genomics research criteria.

Authors:  Merrill Goozner
Journal:  J Natl Cancer Inst       Date:  2011-06-22       Impact factor: 13.506

5.  Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification.

Authors:  M E Gorre; M Mohammed; K Ellwood; N Hsu; R Paquette; P N Rao; C L Sawyers
Journal:  Science       Date:  2001-06-21       Impact factor: 47.728

6.  Preanalytical aspects: a neglected issue.

Authors:  Hartmut Juhl
Journal:  Scand J Clin Lab Invest Suppl       Date:  2010

7.  Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors.

Authors:  Steven Jm Jones; Janessa Laskin; Yvonne Y Li; Obi L Griffith; Jianghong An; Mikhail Bilenky; Yaron S Butterfield; Timothee Cezard; Eric Chuah; Richard Corbett; Anthony P Fejes; Malachi Griffith; John Yee; Montgomery Martin; Michael Mayo; Nataliya Melnyk; Ryan D Morin; Trevor J Pugh; Tesa Severson; Sohrab P Shah; Margaret Sutcliffe; Angela Tam; Jefferson Terry; Nina Thiessen; Thomas Thomson; Richard Varhol; Thomas Zeng; Yongjun Zhao; Richard A Moore; David G Huntsman; Inanc Birol; Martin Hirst; Robert A Holt; Marco A Marra
Journal:  Genome Biol       Date:  2010-08-09       Impact factor: 13.583

8.  Personal omics profiling reveals dynamic molecular and medical phenotypes.

Authors:  Rui Chen; George I Mias; Jennifer Li-Pook-Than; Lihua Jiang; Hugo Y K Lam; Rong Chen; Elana Miriami; Konrad J Karczewski; Manoj Hariharan; Frederick E Dewey; Yong Cheng; Michael J Clark; Hogune Im; Lukas Habegger; Suganthi Balasubramanian; Maeve O'Huallachain; Joel T Dudley; Sara Hillenmeyer; Rajini Haraksingh; Donald Sharon; Ghia Euskirchen; Phil Lacroute; Keith Bettinger; Alan P Boyle; Maya Kasowski; Fabian Grubert; Scott Seki; Marco Garcia; Michelle Whirl-Carrillo; Mercedes Gallardo; Maria A Blasco; Peter L Greenberg; Phyllis Snyder; Teri E Klein; Russ B Altman; Atul J Butte; Euan A Ashley; Mark Gerstein; Kari C Nadeau; Hua Tang; Michael Snyder
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

9.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

Authors:  Marco Gerlinger; Andrew J Rowan; Stuart Horswell; James Larkin; David Endesfelder; Eva Gronroos; Pierre Martinez; Nicholas Matthews; Aengus Stewart; Charles Swanton; M Math; Patrick Tarpey; Ignacio Varela; Benjamin Phillimore; Sharmin Begum; Neil Q McDonald; Adam Butler; David Jones; Keiran Raine; Calli Latimer; Claudio R Santos; Mahrokh Nohadani; Aron C Eklund; Bradley Spencer-Dene; Graham Clark; Lisa Pickering; Gordon Stamp; Martin Gore; Zoltan Szallasi; Julian Downward; P Andrew Futreal
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

10.  RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF.

Authors:  Poulikos I Poulikakos; Chao Zhang; Gideon Bollag; Kevan M Shokat; Neal Rosen
Journal:  Nature       Date:  2010-03-18       Impact factor: 49.962

View more
  2 in total

1.  Participant Attitudes Toward an Intensive Trial of Multiple Biopsies, Multidimensional Molecular Analysis, and Reporting of Results in Metastatic Triple-Negative Breast Cancer.

Authors:  Nicole M Kuderer; Kimberly A Burton; Sibel Blau; Francis Senecal; Vijayakrishna K Gadi; Stephanie Parker; Elisabeth Mahen; David Veenstra; Josh J Carlson; Gary H Lyman; C Anthony Blau
Journal:  JCO Precis Oncol       Date:  2017-08-16

2.  Safety, Feasibility, and Merits of Longitudinal Molecular Testing of Multiple Metastatic Sites to Inform mTNBC Patient Treatment in the Intensive Trial of Omics in Cancer.

Authors:  Kimberly A Burton; Elisabeth Mahen; Eric Quentin Konnick; Sibel Blau; Michael O Dorschner; Arturo B Ramirez; Stephen C Schmechel; Chaozhong Song; Rahul Parulkar; Stephanie Parker; Francis Mark Senecal; Colin C Pritchard; Brigham H Mecham; Christopher Szeto; Patricia Spilman; Jingchun Zhu; Vijayakrishna K Gadi; Roy Ronen; Jackie Stilwell; Eric Kaldjian; Janusz Dutkowski; Stephen Charles Benz; Shahrooz Rabizadeh; Patrick Soon-Shiong; C Anthony Blau
Journal:  JCO Precis Oncol       Date:  2022-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.